Cancer is a disease of aging and, as the world's population ages, the number of older
persons with cancer is increasing and will make up a growing share of the oncology …

As the worldwide population ages, oncologists are often required to make difficult and
complex decisions regarding the treatment of older people (aged 65 years and older) with …

Purpose To provide guidance regarding the practical assessment and management of
vulnerabilities in older patients undergoing chemotherapy. Methods An Expert Panel was …

Frailty, an age-related condition of increased vulnerability to acute endogenous or
exogenous stressors, is a key barrier to successful treatment of cancer in older people. In …

As the population of cancer survivors has grown into the millions, there has been increasing
emphasis on understanding how the late effects of treatment affect survivors' ability to return …

Importance Older patients with cancer and their caregivers worry about the effects of cancer
treatment on aging-related domains (eg, function and cognition). Quality conversations with …

Background The median age of prostate cancer diagnosis is 66 years, and the median age
of men who die of the disease is eighty years. The public health impact of prostate cancer is …

Geriatric medicine is a speciality that has historically relied on team working to best serve
patients. The nature of frailty in older people means that people present with numerous …

Background: Frailty is a syndrome associated with increased vulnerability and an important
predictor of outcomes in older cancer patients. Systematic assessments to identify frailty are …

Evidence for the cognitive impact of cancer and cancer treatments has grown over the last
20 years based on studies ranging from prospective assessments with neuropsychological …